LICENSE AGREEMENTLicense Agreement • March 7th, 2008 • Alfacell Corp • Biological products, (no disgnostic substances) • New York
Contract Type FiledMarch 7th, 2008 Company Industry JurisdictionThis License Agreement (the “Agreement”) is made and entered into as of January 14, 2008 (the “Effective Date”), between Alfacell Corporation, a Delaware corporation with its principal place of business at 300 Atrium Drive, Somerset, New Jersey 08873 (“Alfacell”), and Par Pharmaceutical, Inc., a Delaware corporation with its principal place of business at 300 Tice Boulevard, Woodcliff Lake, New Jersey 07677 (“Par”). Alfacell and Par may be referred to herein individually as a “Party”, or together as the “Parties”.
LICENSE AGREEMENTLicense Agreement • February 29th, 2008 • Par Pharmaceutical Companies, Inc. • Pharmaceutical preparations • New York
Contract Type FiledFebruary 29th, 2008 Company Industry JurisdictionThis License Agreement (the “Agreement”) is made and entered into as of January 14, 2008 (the “Effective Date”), between Alfacell Corporation, a Delaware corporation with its principal place of business at 300 Atrium Drive, Somerset, New Jersey 08873 (“Alfacell”), and Par Pharmaceutical, Inc., a Delaware corporation with its principal place of business at 300 Tice Boulevard, Woodcliff Lake, New Jersey 07677 (“Par”). Alfacell and Par may be referred to herein individually as a “Party”, or together as the “Parties”.